(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

D

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

D

ST13

US500000090497833

Class

5, 42

Filing

90497833

Registration

7588754

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

38

Latest update

12/03/2024

Trademark type

Combined

Nice classes

5, 42

Filing date

01/29/2021

Registration date

12/03/2024

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

12/03/2024

Last transaction

12/03/2024

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

08/05/2024

First use in commerce

08/05/2024

Drawing code

3

Owner type

03

Owner location

Carlsbad, CA, US

Examiner

MCCAULEY, BRENDAN D

Law office

M50

Current location

PUBLICATION AND ISSUE SECTION

Mark description

The mark consists of a stylized letter "D" in which the vertical left hand side is comprised of a spiral of two lines and the right hand portion is comprised of two parallel curved lines with a hollow center.

Holders and representatives

Holders

Design Therapeutics, Inc.

Representatives

Ava R. Miller WILSON SONSINI GOODRICH & ROSATI

Technical classification

Nice Classes

Class 5Class 42

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Pharmaceutical preparations for the treatment of degenerative disorders and diseasesocular disorders and diseasescancer; small molecule therapiespharmaceutical preparationsfor the treatment of degenerative disorders and diseasesocular disorders and diseasescancer

Class 42

Pharmaceutical research and products development of pharmaceuticals for the treatment of degenerative disorders and diseasesocular disorders and diseasescancer; productscientificpharmaceutical research and development in the field of small molecule therapeutics; scientific research for medical purposes in the field of degenerative disorders and diseasesocular disorders and diseasescancer; medical and scientific research in the field of pharmaceuticals

Publications

History of USPTO decisions and trademark events.

38 publications found

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

12/03/2024

R.PR

REGISTERED-PRINCIPAL REGISTER

12/03/2024

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

11/12/2024

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

11/12/2024

SUPC

STATEMENT OF USE PROCESSING COMPLETE

11/12/2024

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

11/12/2024

IUAF

USE AMENDMENT FILED

09/10/2024

EISU

TEAS STATEMENT OF USE RECEIVED

09/10/2024

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

04/30/2024

EX4G

SOU EXTENSION 4 GRANTED

04/29/2024

EXT4

SOU EXTENSION 4 FILED

04/29/2024

EEXT

SOU TEAS EXTENSION RECEIVED

04/29/2024

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

10/24/2023

EX3G

SOU EXTENSION 3 GRANTED

10/20/2023

EXT3

SOU EXTENSION 3 FILED

10/20/2023

EEXT

SOU TEAS EXTENSION RECEIVED

10/20/2023

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

05/17/2023

EX2G

SOU EXTENSION 2 GRANTED

05/15/2023

EXT2

SOU EXTENSION 2 FILED

05/15/2023

EEXT

SOU TEAS EXTENSION RECEIVED

05/15/2023

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

11/17/2022

EX1G

SOU EXTENSION 1 GRANTED

11/15/2022

EXT1

SOU EXTENSION 1 FILED

11/15/2022

EEXT

SOU TEAS EXTENSION RECEIVED

11/15/2022

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

05/17/2022

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

03/22/2022

PUBO

PUBLISHED FOR OPPOSITION

03/22/2022

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

03/02/2022

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

02/16/2022

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

02/16/2022

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

02/15/2022

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

02/15/2022

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

08/23/2021

GNRT

NON-FINAL ACTION E-MAILED

08/23/2021

CNRT

NON-FINAL ACTION WRITTEN

08/23/2021

DOCK

ASSIGNED TO EXAMINER

08/18/2021

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

05/01/2021

NWAP

NEW APPLICATION ENTERED

02/02/2021

Continuous trademark protection

Get notified about every new filing that threatens D or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.